Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 27;27(8):1285-1293.
doi: 10.1093/ibd/izaa349.

The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time

Ruth Ann Marrie  1   2   3 , Lesley A Graff  3   4 , John D Fisk  5 , Scott B Patten  6 , Charles N Bernstein  1   3
Affiliations

The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time

Ruth Ann Marrie et al. Inflamm Bowel Dis. .

Abstract

Brackground: We aimed to examine associations between elevated symptoms of depression and anxiety and disease activity in inflammatory bowel disease (IBD). Previous findings have been inconsistent and have not accounted for variability in the courses of these conditions over time.

Methods: We followed 247 participants with IBD (153 Crohn's disease [CD], 94 ulcerative colitis [UC]) for 3 years. Annually, participants underwent an abdominal examination, reported therapies used for IBD, and completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. We evaluated associations of elevated symptoms (scores ≥11) of anxiety (HADS-A) and depression (HADS-D) with the presence of active IBD as measured using the Powell Tuck Index for UC and the Harvey-Bradshaw Disease Activity Index for CD. We employed logistic regression with generalized estimating equations, simultaneously estimating between-person and within-person effects.

Results: Of 247 participants, 15 (6.1%) had elevated symptoms of depression (HADS-D ≥11) at enrollment, 41 (16.6%) had elevated symptoms of anxiety (HADS-A ≥11), and 101 (40.9%) had active IBD. On average, individuals with elevated symptoms of depression (odds ratio [OR], 6.27; 95% CI, 1.39-28.2) and anxiety (OR, 2.17; 95% CI, 1.01-4.66) had increased odds of active IBD. Within individuals, elevations in symptoms of depression over time were associated with increased odds of active IBD (OR, 2.70; 95% CI, 1.15-6.34), but elevated symptoms of anxiety were not. After adjustment for covariates (including disease activity), elevated symptoms of depression were also associated with increased odds of biologic therapy use (OR, 2.02; 95% CI, 1.02-4.00).

Conclusion: Symptoms of depression and anxiety are associated with disease activity in IBD over time. Reducing these symptoms should be incorporated into the management of IBD.

Keywords: IBD; anxiety; depression; mood disorders; self-reported outcomes; symptoms.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Directed acyclic graph of the hypothesized association between symptoms of depression and anxiety and inflammatory bowel disease activity.
Figure 2.
Figure 2.
Percentage of participants with clinically meaningful symptoms of depression or anxiety and inflammatory bowel disease activity by study visit.
See this image and copyright information in PMC

Comment in

References

    1. Marrie RA, Walld R, Bolton JM, et al. ; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease . Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. J Psychosom Res. 2017;101:17–23. - PubMed
    1. Szigethy EM, Allen JI, Reiss M, et al. . White paper AGA: the impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2017;15:986–997. - PubMed
    1. Click B, Ramos Rivers C, Koutroubakis IE, et al. . Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1442–1449. - PMC - PubMed
    1. Limsrivilai J, Stidham RW, Govani SM, et al. . Factors that predict high health care utilization and costs for patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2017;15:385–392.e2. - PMC - PubMed
    1. Alexakis C, Kumar S, Saxena S, et al. . Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:225–235. - PubMed

Publication types